Innovative Alternatives in AF Management: LAAC vs NOACs

Created using ChatSlide

This keynote presentation delves into a pivotal international study on Left Atrial Appendage Closure (LAAC) as an alternative to Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) for atrial fibrillation (AF) patients. With a robust sample of 3000 patients and a mean age of 71.7, the study underscores LAAC's noninferior efficacy and significantly reduced bleeding risk compared to NOACs. Sponsored by Boston Scientific and published in NEJM, Vol. 394, the research offers promising insights...